Khoury SJ - Search Results

1

Effect of fingolimod vs interferon treatment on OCT measurements and cognitive function in RRMS.

El Ayoubi NK, Bou Reslan SW, Baalbaki MM, Darwish H, Khoury SJ. El Ayoubi NK, et al. Among authors: khoury sj. Mult Scler Relat Disord. 2021 Aug;53:103041. doi: 10.1016/j.msard.2021.103041. Epub 2021 May 23. Mult Scler Relat Disord. 2021. PMID: 34051694

2

Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.

Mouhieddine TH, Darwish H, Fawaz L, Yamout B, Tamim H, Khoury SJ. Mouhieddine TH, et al. Among authors: khoury sj. Clin Immunol. 2015 May;158(1):59-66. doi: 10.1016/j.clim.2015.03.011. Epub 2015 Mar 21. Clin Immunol. 2015. PMID: 25805657

3

Safety and efficacy of reduced fingolimod dosage treatment.

Yamout BI, Zeineddine MM, Sawaya RA, Khoury SJ. Yamout BI, et al. Among authors: khoury sj. J Neuroimmunol. 2015 Aug 15;285:13-5. doi: 10.1016/j.jneuroim.2015.05.012. Epub 2015 May 15. J Neuroimmunol. 2015. PMID: 26198913

4

Serum 25-hydroxyvitamin D predicts cognitive performance in adults.

Darwish H, Zeinoun P, Ghusn H, Khoury B, Tamim H, Khoury SJ. Darwish H, et al. Among authors: khoury sj, khoury b. Neuropsychiatr Dis Treat. 2015 Aug 25;11:2217-23. doi: 10.2147/NDT.S87014. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26346368 Free PMC article.

5

Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.

Yamout BI, Zeineddine MM, Tamim H, Khoury SJ. Yamout BI, et al. Among authors: khoury sj. J Neuroimmunol. 2015 Dec 15;289:93-7. doi: 10.1016/j.jneuroim.2015.10.015. Epub 2015 Oct 26. J Neuroimmunol. 2015. PMID: 26616877

6

ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis.

Khoury SJ, Rochon J, Ding L, Byron M, Ryker K, Tosta P, Gao W, Freedman MS, Arnold DL, Sayre PH, Smilek DE; ACCLAIM Study Group. Khoury SJ, et al. Mult Scler. 2017 Apr;23(5):686-695. doi: 10.1177/1352458516662727. Epub 2016 Aug 5. Mult Scler. 2017. PMID: 27481207 Free PMC article. Clinical Trial.

7

Retinal measures correlate with cognitive and physical disability in early multiple sclerosis.

El Ayoubi NK, Ghassan S, Said M, Allam J, Darwish H, Khoury SJ. El Ayoubi NK, et al. Among authors: khoury sj. J Neurol. 2016 Nov;263(11):2287-2295. doi: 10.1007/s00415-016-8271-4. Epub 2016 Aug 20. J Neurol. 2016. PMID: 27544501

8

Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.

Yamout BI, Abou Zeid N, Taha AJ, Zeineddine MM, Khoury SJ. Yamout BI, et al. Among authors: khoury sj. Mult Scler Relat Disord. 2016 Sep;9:122-4. doi: 10.1016/j.msard.2016.07.012. Epub 2016 Jul 25. Mult Scler Relat Disord. 2016. PMID: 27645358

9

Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.

El Ayoubi NK, Khoury SJ. El Ayoubi NK, et al. Among authors: khoury sj. Neurotherapeutics. 2017 Jan;14(1):135-147. doi: 10.1007/s13311-016-0486-7. Neurotherapeutics. 2017. PMID: 27757816 Free PMC article. Review.

10

Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients.

Darwish H, Haddad R, Osman S, Ghassan S, Yamout B, Tamim H, Khoury S. Darwish H, et al. Sci Rep. 2017 Apr 4;7:45926. doi: 10.1038/srep45926. Sci Rep. 2017. PMID: 28374837 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters